Which option lists the delirium prevention medications?

Which option lists the delirium prevention medications?

• A. Dexmedetomidine hydrochloride, olanzapine, ramelteon, risperidone
• B. Haloperidol and lorazepam
• C. Chlorpromazine, haloperidol
• D. Ramelteon

Answer: (A)

Delirium prevention relies on using meds that help maintain a stable sleep-wake cycle and provide gentler, more physiology-friendly sedation, which can lower the risk of delirium in at‑risk patients. Dexmedetomidine offers sedation that preserves arousability and has been shown in ICU studies to reduce delirium incidence compared with benzodiazepines. Ramelteon, a melatonin receptor agonist, helps regulate sleep patterns with fewer cognitive side effects, and evidence supports its role in lowering delirium risk in elderly or high-risk surgical/ICU patients. Olanzapine and risperidone, as atypical antipsychotics, are used in some protocols to prevent delirium by mitigating agitation and delirium-related psychosis, with the advantage of a lower risk of extrapyramidal symptoms than older antipsychotics, though they require careful monitoring for metabolic effects and QT changes. In contrast, benzodiazepines like lorazepam can worsen delirium, and haloperidol is typically used for treatment or agitation management rather than routine prevention. Putting these together, the combination of dexmedetomidine, olanzapine, ramelteon, and risperidone aligns with strategies aimed at preventing delirium in at-risk patients.

Delirium prevention relies on using meds that help maintain a stable sleep-wake cycle and provide gentler, more physiology-friendly sedation, which can lower the risk of delirium in at‑risk patients. Dexmedetomidine offers sedation that preserves arousability and has been shown in ICU studies to reduce delirium incidence compared with benzodiazepines. Ramelteon, a melatonin receptor agonist, helps regulate sleep patterns with fewer cognitive side effects, and evidence supports its role in lowering delirium risk in elderly or high-risk surgical/ICU patients. Olanzapine and risperidone, as atypical antipsychotics, are used in some protocols to prevent delirium by mitigating agitation and delirium-related psychosis, with the advantage of a lower risk of extrapyramidal symptoms than older antipsychotics, though they require careful monitoring for metabolic effects and QT changes. In contrast, benzodiazepines like lorazepam can worsen delirium, and haloperidol is typically used for treatment or agitation management rather than routine prevention. Putting these together, the combination of dexmedetomidine, olanzapine, ramelteon, and risperidone aligns with strategies aimed at preventing delirium in at-risk patients.